Clinical Trial: Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children
Study Status: Completed
Recruit Status: RECRUITING
Condition: Vaccine Reaction
Study Type: INTERVENTIONAL
Official Title: A Phase III, Observer-Blind, Randomized, Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children Aged 12-17 Years in Indonesia
Brief Summary:
A Phase III, Observer-blind, randomized, active-controlled prospective intervention study
Read more